Vonoprazan Study In Patients With Erosive Esophagitis to Evaluate Long-term Safety: A Study to Evaluate the Safety of Long-term Administration of Vonoprazan in Maintenance Treatment in Patients With Erosive Esophagitis (EE)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 08 Apr 2017
At a glance
- Drugs Vonoprazan (Primary) ; Lansoprazole
- Indications Erosive oesophagitis
- Focus Adverse reactions
- Acronyms VISION
- Sponsors Takeda
- 03 Apr 2017 Planned number of patients changed from 195 to 202.
- 03 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 22 Apr 2016 Status changed from not yet recruiting to recruiting.